GlassScriptPhysician profile
Andrew Michael Stone
NPI 1407458839
$1,770.17
in general payments reported to CMS, 2019-2025
9 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.55 · 2023: $49.83 · 2024: $1,240 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $757.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,043.23 | 2023-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $165.92 | 2024 | Ovitex 2s |
| Polynovo North America LLC | $142.72 | 2025 | Novosorb Btm |
| Davol INC. | $127.61 | 2025 | Phasix Mesh |
| Baxter Healthcare | $100.00 | 2025 | Perclot |
| Urgo Medical North America, LLC | $97.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Innovation Technologies INC | $37.44 | 2024 | Irrisept |
| Lemaitre Vascular, INC. | $29.27 | 2022-2024 | Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $26.51 | 2023 | Gore Excluder Aaa Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.